Anika Therapeutics ANIK Change in Inventories
Change in Inventories at other companies
Other financials
Where this comes from
Reported directly by Anika Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.
The official record: Anika Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Anika Therapeutics's change in inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Anika Therapeutics's change in inventories?
- Anika Therapeutics (ANIK) reported change in inventories of $5.41M in Q1 2026.
- How has Anika Therapeutics's change in inventories changed year-over-year?
- Anika Therapeutics's change in inventories increased by 1133.8% year-over-year, from -$523K to $5.41M.
- What is the long-term trend for Anika Therapeutics's change in inventories?
- Over 2 years (2021 to 2023), Anika Therapeutics's change in inventories has grown at a 26.5% compound annual growth rate (CAGR), from $7.12M to $11.4M.
- What does change in inventories mean?
- Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.